Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 25, 1996

View Archived Issues

Merck & Co. cephalosporins active against MRSA, MRCNS

Lilly claims structurally novel NK1 antagonists

Maxi-K channel modulators from Bristol-Myers Squibb

More antiobesity proteins reported by Lilly

Sandoz claims MAbs against Lewis group antigens for therapeutic use

New class of antibacterial agents discovered by Zeneca

SNX-111 effective in chronic intractable pain

Zonagen allowed further patent coverage for zona pellucida proteins

Marinol promising for geriatric AD

P&U and PRIZM begin ophthalmological collaboration

GBS vaccine proven safe and immunogenic

Research suggests improved treatment for anemia

Glaxo Wellcome to take control of Japanese joint venture

Nyotran progresses towards market introduction

Neose reports promising phase I results for novel antiulcer drug

Milestone achieved in Millennium/Roche research collaboration

Three additional approvals for Rilutek

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...